49 results
Page 2 of 3
8-K
EX-99.1
wn2gqq
15 May 23
Checkpoint Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
4:21pm
8-K
EX-99.1
jnheix9ii5i2s ww1bn
4 Apr 23
Checkpoint Therapeutics Announces $6.1 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
6:05am
424B5
vzd99fn
4 Apr 23
Prospectus supplement for primary offering
6:03am
8-K
EX-99.1
7q97qm6jnuy965hrj8y2
31 Mar 23
Checkpoint Therapeutics Reports Full-Year 2022 Financial Results and Recent Corporate Highlights
6:00am
8-K
EX-99.1
djugrestq348x2hhn
16 Dec 22
Checkpoint Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
7:05am
424B5
gyaokcwy
16 Dec 22
Prospectus supplement for primary offering
7:00am
8-K
EX-99.1
33n2zu k85j93k32n
5 Dec 22
Checkpoint Therapeutics Announces Reverse Stock Split
4:45pm
8-K
EX-99.1
gh9po715hw brw9a
8 Nov 22
Checkpoint Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
5:43pm
8-K
EX-99.1
83ai31y9 9e40q3
12 Aug 22
Checkpoint Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
8:15am
8-K
EX-99.1
r2kfhvw lz6523e2cbe
16 Jun 22
Other Events
7:45am
8-K
EX-99.1
4o1qzyxkpiocxtmr
12 May 22
Checkpoint Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate Highlights
4:45pm
8-K
EX-99.1
prsljc 4l
28 Mar 22
Checkpoint Therapeutics Reports Full-Year 2021 Financial Results and Recent Corporate Highlights
7:53am
8-K
EX-99.1
bc88215dy60nfg0dx8l
25 Jan 22
Other Events
7:45am